A detailed history of Peoples Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Peoples Bank holds 4,013 shares of ABT stock, worth $461,454. This represents 0.23% of its overall portfolio holdings.

Number of Shares
4,013
Previous 3,898 2.95%
Holding current value
$461,454
Previous $405,000 12.84%
% of portfolio
0.23%
Previous 0.21%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$100.07 - $118.13 $11,508 - $13,584
115 Added 2.95%
4,013 $457,000
Q2 2024

Jul 22, 2024

SELL
$100.73 - $112.44 $5,540 - $6,184
-55 Reduced 1.39%
3,898 $405,000
Q1 2024

May 03, 2024

SELL
$109.52 - $120.96 $13,142 - $14,515
-120 Reduced 2.95%
3,953 $449,000
Q4 2023

Jan 25, 2024

SELL
$90.19 - $110.4 $5,501 - $6,734
-61 Reduced 1.48%
4,073 $448,000
Q3 2023

Oct 26, 2023

SELL
$95.53 - $114.62 $34,199 - $41,033
-358 Reduced 7.97%
4,134 $400,000
Q2 2023

Jul 28, 2023

SELL
$100.78 - $112.29 $2,116 - $2,358
-21 Reduced 0.47%
4,492 $489,000
Q1 2023

Apr 24, 2023

SELL
$96.86 - $114.01 $11,816 - $13,909
-122 Reduced 2.63%
4,513 $456,000
Q4 2022

Jan 31, 2023

SELL
$95.06 - $111.52 $160,176 - $187,911
-1,685 Reduced 26.66%
4,635 $508,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $19,545 - $22,630
-202 Reduced 3.1%
6,320 $612,000
Q2 2022

Jul 29, 2022

SELL
$102.07 - $123.37 $4,082 - $4,934
-40 Reduced 0.61%
6,522 $709,000
Q1 2022

May 03, 2022

BUY
$114.02 - $139.04 $8,323 - $10,149
73 Added 1.12%
6,562 $777,000
Q4 2021

Jan 27, 2022

BUY
$115.53 - $141.46 $24,030 - $29,423
208 Added 3.31%
6,489 $913,000
Q3 2021

Oct 27, 2021

SELL
$116.66 - $129.06 $41,297 - $45,687
-354 Reduced 5.34%
6,281 $742,000
Q2 2021

Aug 02, 2021

SELL
$105.79 - $124.53 $19,571 - $23,038
-185 Reduced 2.71%
6,635 $769,000
Q1 2021

Apr 19, 2021

BUY
$108.84 - $128.23 $11,210 - $13,207
103 Added 1.53%
6,820 $817,000
Q4 2020

Feb 01, 2021

BUY
$105.0 - $114.42 $13,755 - $14,989
131 Added 1.99%
6,717 $735,000
Q3 2020

Oct 23, 2020

BUY
$91.64 - $111.29 $38,763 - $47,075
423 Added 6.86%
6,586 $717,000
Q2 2020

Jul 27, 2020

BUY
$76.57 - $98.0 $92,266 - $118,090
1,205 Added 24.3%
6,163 $563,000
Q1 2020

May 01, 2020

SELL
$62.82 - $91.86 $691 - $1,010
-11 Reduced 0.22%
4,958 $391,000
Q4 2019

Jan 28, 2020

BUY
$78.51 - $87.4 $14,367 - $15,994
183 Added 3.82%
4,969 $432,000
Q3 2019

Oct 18, 2019

BUY
$81.84 - $88.74 $6,056 - $6,566
74 Added 1.57%
4,786 $400,000
Q2 2019

Aug 07, 2019

BUY
$72.88 - $85.0 $12,098 - $14,110
166 Added 3.65%
4,712 $396,000
Q1 2019

May 06, 2019

BUY
$66.22 - $80.06 $19,998 - $24,178
302 Added 7.12%
4,546 $363,000
Q4 2018

Feb 26, 2019

BUY
$65.56 - $74.27 $83,261 - $94,322
1,270 Added 42.7%
4,244 $307,000
Q3 2018

Oct 31, 2018

BUY
$60.81 - $73.36 $180,848 - $218,172
2,974 New
2,974 $218,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Peoples Bank Portfolio

Follow Peoples Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Bank , based on Form 13F filings with the SEC.

News

Stay updated on Peoples Bank with notifications on news.